Celldex Therapeutics, Inc. (CLDX)
29.21
+0.65
(+2.28%)
USD |
NASDAQ |
Jun 09, 14:10
Celldex Therapeutics Total Liabilities (Quarterly) : 55.03M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.371B |
| Kura Oncology, Inc. | 544.67M |
| Syndax Pharmaceuticals, Inc. | 431.05M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 511.25M |
| Shareholders Equity (Quarterly) | 456.23M |
| Debt to Equity Ratio | 0.0042 |
| Current Ratio | 8.922 |
| Net Debt Paydown Yield | 0.02% |